TNF Pharmaceuticals Inc (NASDAQ:TNFA) price on Thursday, June 12, fall -6.76% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $0.15.
A look at the stock’s price movement, the close in the last trading session was $0.16. Turning to its 52-week performance, $2.24 and $0.15 were the 52-week high and 52-week low respectively. Overall, TNFA moved -14.27% over the past month.
TNF Pharmaceuticals Inc’s market cap currently stands at around $2.17 million, with investors looking forward to this quarter’s earnings report slated for in July.
Turning to the stock’s technical picture we see that short term indicators suggest on average that TNFA is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
TNFA’s current price about -10.41% and -27.10% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 38.07, while 7-day volatility ratio is 5.57% and 6.31% in the 30-day chart. Further, TNF Pharmaceuticals Inc (TNFA) has a beta value of 2.07, and an average true range (ATR) of 0.03.
If we refocus on TNF Pharmaceuticals Inc (NASDAQ:TNFA), historical trading data shows that trading volumes averaged 3.91 million over the past 3 months. The company’s latest data on shares outstanding shows there are 14.18 million shares.
The 4.98% of TNF Pharmaceuticals Inc’s shares are in the hands of company insiders while institutional holders own 1.44% of the company’s shares. Current price change has pushed the stock -86.68% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the TNFA stock continues to rise going into the next quarter.
